- Home
- CTSO vs LODE Comparison
CTSO vs LODE Comparison
Compare CTSO & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- LODE
- Stock Information
- Founded
- CTSO 1997
- LODE 2008
- Country
- CTSO United States
- LODE United States
- Employees
- CTSO N/A
- LODE N/A
- Industry
- CTSO Medical/Dental Instruments
- LODE Major Chemicals
- Sector
- CTSO Health Care
- LODE Industrials
- Exchange
- CTSO Nasdaq
- LODE Nasdaq
- Market Cap
- CTSO 61.3M
- LODE N/A
- IPO Year
- CTSO N/A
- LODE N/A
- Fundamental
- Price
- CTSO $1.00
- LODE $2.54
- Analyst Decision
- CTSO Strong Buy
- LODE Buy
- Analyst Count
- CTSO 3
- LODE 1
- Target Price
- CTSO $4.67
- LODE $26.00
- AVG Volume (30 Days)
- CTSO 83.4K
- LODE 392.0K
- Earning Date
- CTSO 05-08-2025
- LODE 03-06-2025
- Dividend Yield
- CTSO N/A
- LODE N/A
- EPS Growth
- CTSO N/A
- LODE N/A
- EPS
- CTSO N/A
- LODE N/A
- Revenue
- CTSO $37,739,531.00
- LODE $3,016,163.00
- Revenue This Year
- CTSO $9.20
- LODE $17.86
- Revenue Next Year
- CTSO $11.64
- LODE N/A
- P/E Ratio
- CTSO N/A
- LODE N/A
- Revenue Growth
- CTSO 1.80
- LODE 136.66
- 52 Week Low
- CTSO $0.70
- LODE $1.30
- 52 Week High
- CTSO $1.61
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- CTSO 44.00
- LODE 44.16
- Support Level
- CTSO $0.97
- LODE $2.35
- Resistance Level
- CTSO $1.08
- LODE $2.68
- Average True Range (ATR)
- CTSO 0.07
- LODE 0.21
- MACD
- CTSO -0.01
- LODE 0.04
- Stochastic Oscillator
- CTSO 17.53
- LODE 34.48
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.